EKF Diagnostics Holdings plc is a global, integrated medical diagnostics business. EKF designs and manufactures diagnostic equipment for use within Point-of-Care settings. The company's product portfolio includes small blood analysers and associated consumables used in testing patients for conditions including diabetes and anaemia. EKF is also a manufacturer of liquid reagents, enzymes and fermenation products used in the Central Laboratory market.
Private/Public:public
Phone:0044 (0)29 20 710570
Fax:0044 (0)29 20 705715
Email:[email protected]
Website:https://www.ekfdiagnostics.com/
Address:Avon House, 19 Stanwell Road, Penarth, Cardiff CF64 2EZ, United Kingdom
API/Biologicals Production
API/Biologics development and manufacturing
Diagnostics
Diagnostic services/equipment
- Diagnostic assay development/manufacturing
- Diagnostic equipment manufacturing
- Diagnostic laboratory developed testing (LTDs)
- Diagnostic technologies/capabilities
United Kingdom
- (12.Jan.2021) Trading Update
- (14.Dec.2020) Approval of Dividend in Specie of Investment in Trellus Health
- (10.Dec.2020) Result of General Meeting
- (09.Nov.2020) Trading Update
- (28.Oct.2020) EKF and Kantaro Partner to Market Quantitative COVID-19 Antibody Testing in the UK and Europe
- (26.Oct.2020) Dividend Confirmation
- (02.Oct.2020) Trading Update
- (01.Oct.2020) Exercise of Options and Total Voting Rights
- (14.Sep.2020) Half-Year Report
- (20.Aug.2020) US$5m Funding into Trellus Health to Transform Care for Complex Chronic Conditions
- (05.Aug.2020) New UK Supply Contract for COVID-19 Sample Collection Kits
- (14.Jul.2020) Trading Update and Update on COVID-19 Related Manufacturing Contract
- (15.May.2020) Update on Trading and COVID-19 Related Manufacturing Contract
- (05.May.2020) Exercise of Options and Total Voting Rights
- (05.May.2020) Distribution Agreement for Quo-Test HbA1c Analyzer
- (29.Apr.2020) UK Supply Contract for COVID-19 Sample Collection Kits
- (28.Apr.2020) COVID-19 Related Manufacturing Capacity Update
- (27.Apr.2020) Update on COVID-19 Related Manufacturing Contract
- (07.Apr.2020) Final Results
- (20.Mar.2020) Detailed Trading Review Including COVID-19 Update
- (29.Jan.2020) Trading Update